Categories: News

BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE Against WonderFace Device

PRAGUE, Jan. 22, 2026 /PRNewswire/ — BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. (“Lexter”), the manufacturer of the WonderFace device.

- Advertisement -

The settlement follows patent infringement litigation initiated by BTL in multiple jurisdictions to protect its proprietary EMFACE® technology. As a result of the settlement, Lexter has agreed to cease the manufacture, global marketing and distribution, and use of facial treatment technologies and associated disposables that simultaneously combine radiofrequency and electrical muscle stimulation.

- Advertisement -

As a leader in medical innovation, BTL owns a robust international patent portfolio protecting fundamental aspects of energy-based technologies.

- Advertisement -

“The global and definitive impact of this settlement testifies to our dedication to defending BTL’s intellectual property and protecting the investments of our customers,” said Tomas Schwarz, CEO of the BTL Group.

- Advertisement -

For more information about EMFACE®, visit www.emface.com.

- Advertisement -

About BTL
Founded in 1993, BTL is a global leader in medical device innovation, providing advanced solutions across aesthetic medicine, dermatology, plastic surgery, rehabilitation, orthopaedics, joint and spine care, dentistry, primary care, and OB/GYN. With more than 200 patents and over 600 in-house engineers, BTL leverages science and technology to advance non-invasive and therapeutic medical treatments worldwide. Its product portfolio includes EMFACE®, EXION®, EMSCULPT NEO®, EXOMIND®, EMSELLA®, EMVITAL®, and others.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2791403/5728165/BTL_Group_Logo.jpg

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/btl-announces-successful-enforcement-of-patent-rights-relating-to-emface-against-wonderface-device-302666909.html

- Advertisement -

Recent Posts

Pinecone Launches First Serverless Region in Asia with New Singapore Cloud Region, Bringing the Knowledge Infrastructure for AI to the Asia-Pacific Market

Alongside new availability on AWS ap-southeast-1, Pinecone announces Nexus knowledge engine, KnowQL query language, Marketplace,…

31 minutes ago

Kroll Appoints Renowned Professional Services Executive Fred Crawford as Executive Chairman

Fred Crawford brings decades of experience building and scaling advisory firms to help support and…

31 minutes ago

Maropost Launches a New Partner Portal to Supercharge Global Growth

TORONTO, May 4, 2026 /PRNewswire/ -- Maropost, the leading unified commerce platform, today announced the…

31 minutes ago

Lee Cowie appointed CEO of accesso as company accelerates AI strategy

COO steps up as founder Steve Brown passes the baton in planned handover; transition follows…

31 minutes ago

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf…

2 hours ago

Making Waves Across Borders: Manipal Hospitals Presents the First-Ever Sri Lanka-India Open Water Swim by a Couple

BENGALURU, India, May 4, 2026 /PRNewswire/ -- Manipal Hospitals, India's largest pan-India multispecialty hospital network by…

2 hours ago